Home
Invus Global Management reported a 7.8% stake in enGene Therapeutics ENGN · 5,253,159 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.8%
- Last report
- 6.3% · filed 26/01/27
- Shares held
- 5,253,159 sh
- Class
- Common Shares
- Holder
- Invus Global Management
- Event date
- 26/03/31
- Filed
- 26/05/05
7.8% stake · +1.5pp from the last report
- Stake
- 7.8%
- Last report
- 6.3%
- Since last report
- +1.5pp
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Invus Global Management's other 5% stake reports
- Invus Global Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
7.2% stake
675,000 sh
7.2% stake
Filed 09/17
- Invus Global Management
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
9.3% stake
6,256,662 sh
9.3% stake
Filed 08/13
- Invus Global Management
5% stakeScholar Rock Holding
5% stakeScholar Rock Holding
SRRK
8% stake
9,575,013 sh
8% stake
Filed 08/13
- Invus Global Management
5% stakeAbivax
5% stakeAbivax
ABVX
6% stake
4,825,759 sh
6% stake
Filed 08/13
- Invus Global Management
5% stakeHemab Therapeutics Holdings
5% stakeHemab Therapeutics Holdings
COAG
5.1% stake
2,366,235 sh
5.1% stake
Filed 08/07
